Dragan Cicic
Corporate Officer/Principal chez SELLAS LIFE SCIENCES GROUP, INC.
Profil
Dragan Cicic is currently a Member at the American Society of Hematology and the Chief Development Officer & Senior Vice President at SELLAS Life Sciences Group, Inc. Previously, he held positions such as Director, Chief Operating & Medical Officer at Actinium Pharmaceuticals, Inc., Project Director at QED Technologies International, Inc., Chief Operating & Medical Officer at Cactus Ventures, Inc., and Principal at British Broadcasting Corp.
He also served as the Chief Technology Officer at Actinium Pharmaceuticals, Inc. and Senior Vice President at KLUS Pharma, Inc. Dr. Cicic holds a doctorate degree from the University of Belgrade and the School of Medicine (RS), as well as an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Dragan Cicic
| Sociétés | Poste | Début |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Corporate Officer/Principal | - |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Anciens postes connus de Dragan Cicic
| Sociétés | Poste | Fin |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Chief Executive Officer | - |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Chief Tech/Sci/R&D Officer | 18/04/2013 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | Chief Operating Officer | 18/04/2013 |
KLUS Pharma, Inc.
 KLUS Pharma, Inc. BiotechnologyHealth Technology KLUS Pharma, Inc. discovers and develops novel and safer antibody-based therapeutics. The firm specializes in global business development, biologics drug discovery and development, antibody discovery, antibody-drug conjugates(ADC), clinical development, bispecific, multispecific antibody and immuno-oncology. The company was founded in October 2014 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | - |
British Broadcasting Corp.
 British Broadcasting Corp. BroadcastingConsumer Services British Broadcasting Corp. provides broadcasting services. It offers news, sport, weather reports, DVD shopping, videos, travel, capital, culture, music, nature, food and local news. The company was founded by John Charles Walsham Reith in 1922 and is headquartered in White City, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Dragan Cicic
| University of Belgrade | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| School of Medicine (RS) | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | Finance |
British Broadcasting Corp.
British Broadcasting Corp. BroadcastingConsumer Services British Broadcasting Corp. provides broadcasting services. It offers news, sport, weather reports, DVD shopping, videos, travel, capital, culture, music, nature, food and local news. The company was founded by John Charles Walsham Reith in 1922 and is headquartered in White City, the United Kingdom. | Consumer Services |
QED Technologies International, Inc.
 QED Technologies International, Inc. SemiconductorsElectronic Technology QED Technologies International, Inc. develops polishing and metrology technology for semiconductors. The company is based in Rochester, NY. The company was founded in 1996 by Lowell A. Mintz, Donald Golini. The CEO is Bertrand Loy. QED Technologies International was acquired by CMC Materials LLC, part of Entegris, Inc. from July 07, 2022 on July 10, 2006 for $23.50 million. | Electronic Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
KLUS Pharma, Inc.
KLUS Pharma, Inc. BiotechnologyHealth Technology KLUS Pharma, Inc. discovers and develops novel and safer antibody-based therapeutics. The firm specializes in global business development, biologics drug discovery and development, antibody discovery, antibody-drug conjugates(ADC), clinical development, bispecific, multispecific antibody and immuno-oncology. The company was founded in October 2014 and is headquartered in Cranbury, NJ. | Health Technology |
